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Abstract. Despite nutrition interventions, stunting thought to be secondary to underlying environmental enteropathy
(EE) remains pervasive among infants residing in resource-poor countries and remains poorly characterized. From a birth
cohort of 380 children, 65 malnourished infants received 12 weeks of nutritional supplementation with ready-to-use
therapeutic food (RUTF). Eleven children with insufficient response to RUTF underwent upper endoscopy with duodenal
biopsies,whichwere comparedwithU.S., age-matchedspecimens for healthy, celiacdisease, non-celiac villous atrophy,
non-celiac intraepithelial lymphocytosis, and graft-versus-host disease patients. Of the 11 children biopsied, EE was
found in 10 (91%)with one subject with celiac disease.Morphometry demonstrated decreased villus-to-crypt (V:C) ratios
in EE relative to healthy and non-celiac lymphocytosis patients. Environmental enteropathy villus volumes were signifi-
cantly decreased relative to healthy controls. In EE, averageCD3+ cells per 100 epithelial cells andper 1,000μm2of lamina
propria and the number of lamina propria CD20+ B-cell aggregateswere increased relative to all other groups. Our results
indicate that V:C ratios are reduced in EE but are less severe than in celiac disease. Environmental enteropathy intra-
epithelial and lamina propria T lymphocytosis is of greater magnitude than that in celiac disease. The increases in lamina
propria B and T lymphocytes suggest that non-cytolytic lymphocytic activation may be a more prominent feature of EE
relative to celiac disease. These results provide new insights into shared yet distinct histological and immunological
features of EE and celiac disease in children.
INTRODUCTION
Environmental enteropathy (EE) is a malabsorptive condi-
tion that is highly prevalent in residents of low- and middle-
income countries. Although EE has been linked to poor
sanitation and hygiene, the underlying pathophysiology has
not been elucidated.1–5 This may explain the wide variety of
definitions and nomenclature, including tropical enteropa-
thy, environmental enteric dysfunction, and subclinical
malabsorption,5,6 which have been applied to EE. Never-
theless, EE is increasingly recognized as a key factor
underlying malnutrition, deficient immune responses, and
impaired cognitive development in children within low- and
middle-income countries.7
The earliest studies describing enteropathy with the use of
intestinal biopsies were from the 1960s to 1970s8–10 with
study subjects from Asia, Africa, the Indian subcontinent, and
Central America. These studies also reported morphological
changes or functional signs of EE in a high proportion of
apparently healthy adults and children.11–14 Functional
measures included clinical or subclinical malabsorption of
macro- andmicronutrients, as well as increased permeability
to small molecules. Despite significant published reports
from the 1970s to 1980s, there was minimal focus on the
underlying pathophysiology of EE. Environmental enterop-
athy has become an active area of investigation over the last
decade. Results of both investigative analyses and clinical
trials have, however, been disappointing, with nutritional in-
terventions failing to improve growth, reduce susceptibility to
infection, and increase oral vaccine responses.15
Given the financial and operational limitations of safely
obtaining intestinal biopsies from very young children in the
community, there have been very few detailed investigations
of human intestinal tissue in this vulnerable patient group in
whom reversal of EE would provide the greatest benefit.
Previous studies have characterized the histopathology of EE
as ranging from normal villi to villous shortening, crypt
hyperplasia, loss of brush-border enzyme expression, and
lamina propria lymphocytic and plasma cell infiltrates.4,5,16–18
Recently, several groups have endeavored to establish animal
models of EE using low-protein diets in combination with
perturbation of the intestinal microbiota.19,20 Although villous
blunting and altered epithelial and mucosal immune
responses were induced, the extent to which these models
recapitulate human disease is difficult to assess, given the
paucity of studies characterizing tissue fromhumanEE cases.
Hence, the aims of the current study, thus, were to define the
histopathologic changes in the small intestine in well-
characterized EE cases and to compare these findings with
U.S. healthy and selected disease controls.
MATERIALS AND METHODS
Study design and participants. Subjects included in this
analysis were part of a prospective community-based active
surveillance birth cohort with an intervention arm that was
designed to investigate growth faltering, response to ready-
to-use therapeutic food (RUTF), and endoscopic evaluation of
children with an inadequate growth response to RUTF. The
study site was in the rural district of Matiari, located in the
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province of Sindh about 200 km (124 miles) north of Karachi,
Pakistan. TheDepartment ofPediatrics andChildHealth at the
Aga Khan University, Pakistan, has established research in-
frastructure and relationships in this area in collaboration with
the Government of Pakistan since 2002 for the purpose of
community-based research.
Enrollment and assessment of newborns were carried out
during routine surveillanceof pregnantwomenof reproductive
age (13–49 years) by community health workers (CHWs).
Study inclusion criteria were 1) newborns aged up to 14 days;
2) absence of any major congenital abnormalities; and 3)
ability to obtain informed consent from parents or guardians.
Infants of families planning tomoveout of the studyareawithin
6 months of birth were excluded from the trial. Enrolled chil-
dren were followed from birth (0–14 days) until 18 months of
age with weekly home visits. At each weekly visit, CHWs
obtainedmorbidity data, including number of days of reported
fever, symptoms of acute respiratory infections (ARI), vomit-
ing, and diarrhea in the preceding week. Days and types of
antibiotics receivedwere recordedatmonthly visits for eachof
the 10 EE biopsy subjects. However, none of these subjects
received antibiotics in the 4–6 weeks before biopsy. All fami-
lies enrolled in the studywereprovidedwith cell phonecontact
information of key study physicians to enable direct and im-
mediate contact in the case of any urgent medical need by the
study participants.
Monthly measurements were recorded by trained CHWs
using standard techniques: child’s weight using a digital in-
fant balance with 20-g precision (TANITA 1584) and the
child’s length with 1-mmprecision (using a rigid length board
with a movable foot piece). Standardization of measure-
ments was ensured through regular staff training and cross-
checks.
Sample section of subjects and controls. Children who
were identified as having moderate (weight-for-height z score
[WHZ] < −2) or severe (WHZ < −3) acute malnutrition at
9 months of age were selected for intervention with educa-
tional counseling and energy dense nutrition supplementation
(Supplemental Figure 1). Educational intervention was pro-
vided over a 2-month period of weekly home visits. Teaching
material covered included benefits of breastfeeding, maternal
diet, and age-appropriate complementary feeding and was
delivered via interactive sessions between the parents and
caregivers using standardized training videos. Nutritional in-
tervention includedprovision ofweight appropriate quantity of
RUTF21 (F-100 formula, 500 kcal/92 g sachet) for 2 months,
with close monitoring of compliance (defined as the pro-
portion of sachets consumed of the total prescribed sachets
that were supplied) which was monitored weekly. Upper
gastrointestinal endoscopies were performed for a subset of
children who did not respond to RUTF. Control subjects were
selected from the tissue archives of the Department of Pa-
thology at the University of Chicago. Duodenal biopsies from
52 age-matched controls were selected and divided into five
distinct groups: healthy normal (25), celiac disease (7), non-
celiac villous atrophy (7), non-celiac intraepithelial lympho-
cytosis (8), and graft-versus-host disease (2).
Of note, all intestinal tissue samples from the Aga Khan
University, Pakistan, were fromour study selection process as
outlined previously andnot fromarchives. Paraffin-embedded
duodenal biopsies were obtained from the Aga Khan Univer-
sity, Pakistan, fromour 10 study subjects. Archival tissue from
the University of Chicago Department of Pathology was used
as outlined previously as controls.
Assessment of micronutrient and celiac disease status.
Bloodwascollected fromall subjectsat the timeof endoscopy ina
venous blood collection tube coated with EDTA (Becton Dick-
inson, Franklin Lakes, NJ) and in a 3–5-mL serum gel yellow-top
vacutainer (Becton Dickinson) at 10 months of age to screen for
micronutrient deficiencies and celiac disease. Whole blood sam-
ples of 3–5 mL each were immediately sent for the following lab-
oratory tests per standard clinical protocol: complete blood count
for hemoglobin (Hb), white blood cell (WBC) count, and cell dif-
ferential (SYSMEX XE 5000; Sysmex Corporation, Kobe, Japan).
Plasma was obtained by centrifuging the BD gel vacutainer
(BectonDickinson)according to themanufacturer’sspecifications
and then aliquoted and stored at−80C. The following assayswere
run on the serum samples: ferritin (Immulite 2000; Siemens,
Erlangen, Germany); B12 concentrations (ADVIA Centaur;
Siemens); transferrin saturation (TSat) % (ADVIA Centaur XP;
Roche,Erlangen,Germany); folic acid (ADVIACentaur;Siemens);
and 25-hydroxy (OH) vitamin D (LIASON XL; DiaSorin, Saluggia,
Italy). Celiac screening investigations consisted of anti-tissue
transglutaminase immunoglobulin A (tTG IgA) (ETIMAX 3000;
DiaSorin, ETIMAX, enzyme-linked immunosorbent assay)
and total serum IgA (ADVIA 1800; Siemens).
Biomarkers were defined as abnormal according to the
following cutoffs: anemia, Hb < 11.0 g/dL guidelines22; leu-
kocytosis, WBC Count > 18.0 × 103 μL (per clinical laboratory
manual); iron deficiency, serum ferritin < 15 μg/L or TSat% <
2023; B12 deficiency, serum B12 < 150 pg/mL24; folate de-
ficiency, serum folic acid < 3 ng/mL25; vitamin D deficiency,
25(OH)D< 20 ng/mL,26 vitaminD insufficiency, 25(OH)D levels
between 20 and 30 ng/mL26; anti-tTG-IgA: < 12 U/mL =
negative, 12–18 U/mL = equivocal, and > 18 U/mL = positive
(per clinical laboratory manual); and total serum IgA =
normal range 0.18–1.7 g/L (per clinical laboratory manual).
Endoscopy and tissue handling. The proximal intestinal
mucosa was biopsied endoscopically by a trained pediatric
gastroenterologist using standardOlympusEvis Exera III CV-190
pediatric endoscope, which has a working channel that allows a
2.8-mmbiopsy forceps.Gastricbiopsieswereobtainedonly if the
mucosa looked endoscopically abnormal inN = 8 of the total 10
subjects. Duodenal biopsies were obtained for all children using
standard biopsy forceps and immediately fixed in 10% neutral
buffered formalin and processed for embedding in paraffin.
TaqMan array card (TAC). The TaqMan low-density array
card or TAC allowsmolecular detection of multiple pathogens
using a customized detection platform for common enteric
pathogens27 that included viruses, bacteria, and helminths.
The TAC card was used to detect microbial targets in duo-
denal aspirates and stool of the N = 10 biopsy subjects. This
platformhasbeenvalidatedpreviously indifferent laboratories
in international multicenter studies.28 Briefly, total nucleic acid
(TNA) was extracted from 400 μL of duodenal aspirates run
through an automatedmagnetic bead–based extractor, using
Roche MagNa Pure Compact isolation kit I (Roche Life Sci-
ences, Mannheim, Germany). All duodenal aspirates were
spiked with internal controls of phocine herpes virus (PhHV)
and MS2 (MS2 bacteriophage) as DNA and RNA targets, re-
spectively, for validation and efficiency of extraction, reverse
transcription, and amplification steps. The TAC protocol was
modified from that of the Next Gen project (Houpt Laboratory,
University of Virginia, Charlottesville, VA). A total of 100 μL of
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TNAwas eluted from theMagNaPure analyzer and 40μLof TNA
was loaded on a TAC card through microfluidic ports. The card
wassealedand runonViiA7 (AppliedBiosystems,ThermoFisher,
Waltham,MA). A total of eight samples were run on a single card
along with extraction blanks (consisting of nuclease-free water
with PhHV and MS2), polymerase chain reaction (PCR) blank
(consisting of nuclease-free water only), and TAC-mixed positive
controls. The samples were considered a valid positive if 1) the
sample’s target cycle threshold value was less than 32, 2)
the reference extraction blank was negative for each target, and
3) the internal control had a cycle threshold value less than 3.
Intestinal tissuehandlingandhematoxylinandeosin (H&E).
Paraffin-embedded duodenal biopsies were obtained from the
Aga Khan University in Pakistan and the University of Chicago
Department of Pathology archives. Helicobacter pylori was
identified using routine H&E staining. De-identified biopsies
archived at the University of Chicago of children with histo-
pathologic diagnoses of 1) non-celiac villous atrophy, 2) non-
celiac intraepithelial lymphocytosis, and 3) normal were used as
comparative groups in our study. These were children who had
underwent endoscopies for a variety of clinical indications, in-
cluding (but not limited to) evaluation of failure to thrive and/or
diarrhea with serology, which was negative for celiac disease.
These subjects were classified as follows based on the ap-
pearance of their duodenal mucosa: healthy normal, celiac,
graft-versus-host-disease (GVHD), non-celiac villous atrophy,
andnon-celiac lymphocytosis.PleaseseeSupplemental Tables
1–3 for details of these clinical indications. After examination of
clinical records, pathology reports, andH&E–stained slides, the
University of Chicago cases were subdivided into normal, non-
celiac lymphocytosis, non-celiac villous atrophy, celiac disease,
and graft-versus-host disease cases.
Morphometry for villus and crypt measurements and
immunohistochemical staining. Measurement of villus
height and crypt depth was performed on the H&E–stained
slides. The slides were scanned using Leica DM4000 micro-
scope using a 20×/NA0.7 PLAN-APO objective, Photomet-
rics® CoolSNAP HQ2 camera for fluorescent images and
ProgRes® C10plus from Jenoptik for bright-field images, and
the slidescan feature using custom journalswithinMetamorph
7 (Molecular Devices, San Jose, CA). Only well-oriented
crypt–villus units within each section were measured. Dis-
tances from the villus tip to crypt–villus junction and to the
crypt base were measured using Metamorph. Villus volume
was calculated by modeling the villus as a cone. Villus width,
that is, diameter, was measured at 1/3 and 2/3 of the villus
height. Villus-to-crypt (V:C) ratios and villus volume could not
bedetermined for graft-versus-host disease casesbecauseof
the absence of representative villi in these biopsies.
Intraepithelial lymphocyte numbers were labeled by anti-
CD3 staining. The slides were baked for 90 minutes at 60C,
washed in xylene three times for 15 minutes, transferred to
100% ethanol, and rehydrated to water through a series of
ethanol solutions. Antigen retrieval was performed for
40 minutes using Dako Target Retrieval Solution (S2367) in a
steamer. After three washes in tris-buffered saline tween
(TBST) (50 mM Tris, pH 7.5, with 0.1% tween-20), incubation
for 20 minutes in 50 mM NH4Cl in tris-buffered saline (TBS)
(50 mM Tris, pH 7.5), three subsequent washes with TBS, and
blocking solution with 0.3 M glycine, 5% bovine serum albu-
min, 10% normal donkey serum, and 10% normal human
serum in TBS, the slides were incubated with antibodies
againstCD3 (#ab16669; Abcam,Cambridge, UnitedKingdom)
andCD20 (#ab9475;Abcam)diluted inblocking solution for 24
hours at 4C. The slideswere thenwashed three times in TBST
and twice with TBS before applying AlexaFluor 488 AffiniPure
F(ab9)2 donkey anti-mouse immunoglobulin G (heavy and light
chains) (#715-546-150; Jackson ImmunoResearch, West
Grove, PA), AlexaFluor 594AffiniPure F(ab9)2 fragment donkey
anti-rabbit (#711-586-152; Jackson ImmunoResearch), and
Hoechst 33342 (1 μg/mL) for 2 hours at room temperature.
After six washes in TBST, the slides were dipped in water and
mounted using ProLong Gold antifade (Thermo Scientific).
Imaging was performed using a Leica DM4000 microscope
configured as aforementioned using a Photometrics Cool-
SNAP HQ2 camera.
Data management and statistical analysis of intesti-
nal tissue. TheWorldHealthOrganization (WHO)ChildGrowth
Standards (WHO Anthro, Geneva, Switzerland) were used to
calculate z scores and categorized stunting as a height-for-age
z score < −2 standard deviation (SD), underweight as a weight-
for-age z score < −2 SD, and wasting as a WHZ < −2 SD.
Scanned images of anti-CD3 and anti-CD20 immunostains
were scored using the threshold function of Metamorph to as-
sess fluorescence intensity. Cells that exceeded threshold
limits were counted as applied, and biopsies were deemed to
be positive. Analysis of variance and t tests were performed for
all morphometric statistical analyses using GraphPad Prism
version 6.00 for Windows and GraphPad Software (La Jolla,
CA, www.graphpad.com). SAS 9.3 (SAS Institute Inc., Cary,
NC) was used to calculate the chi-squared test and compare
B-cell aggregate numbers between different groups.
Ethics statement and study data. Institutional approval
was granted by the Aga Khan University Human Subjects
Committee and the University of Chicago Institutional Review
Board. Data from this study are not available in a public re-
pository but will be made available on request.
RESULTS
Background characteristics of EE biopsy subjects. Of
the 380 children whowere enrolled at birth between November
2012 and April 2013, 65 children had WHZ < −2 and met the
eligibility criteria to receive 12 weeks of intensive nutritional
(RUTF) intervention and educational counseling. Table 1 and
Supplemental Table 4 summarize the background character-
istics of our study cohort of N = 10 EE cases. Maternal age on
average was nearly 27 years with no mothers having had any
formal education; half had their delivery at home. Fifty percent
(N = 5) of all subjects had low birth weight (birth weight < 2,500
g) and N = 6 children (60%) were born preterm (gestational
age < 37weeks), and all the children were breastfed. As noted
in Supplemental Figure 2, recurrent episodes of ARI and di-
arrheawere a predominant featurewith the average number of
diarrheal days per month ranging from 0 to 8 days, whereas
the average number of ARI days per month ranged from 0 to
25 days. The highest average WHZ score was −0.70,
reaching −2.6 just before biopsy at 18 months of age.
Micronutrient status, investigations, and PCRmicrobial
detection summary of EE biopsy subjects. Anemia was
present in N = 7 (70%) of the children with 20% (N = 2) with
leukocytosis (Supplemental Table 4). Almost all children N =
9 (90%) had iron deficiency, one had B12 deficiency, and of
the folate statusmeasured, all (N=9)were normal. Of theN=9
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children who had plasma 25(OH)D levels measured, only one
child was vitamin D sufficient, with the rest being either de-
ficient (N = 3) or insufficient (N = 5). Celiac screening was
performed using serum tTG-IgA, which was negative in nine
subjects and equivocal in one (note: of our total 11 children
biopsied, EE was found in 10 [91%] with one subject with
celiac disease [anti-transglutaminase-IgA level of 97.32U/mL]).
All had normal IgA levels. Of the 10 duodenal aspirate sam-
ples collected, one child was both Giardia spp. and H. pylori
positive, one child hadEnterovirus,Giardia spp., andH. pylori
positive, and finally, one child hadCampylobacter (jejuni and
coli), Giardia spp., and Norovirus GII positive. Helicobacter
pylori and Giardia spp. were the most common pathogens,
being positive in four patients each (Supplemental Table 5).
No stool testing was carried out at clinical presentation or at
the time of endoscopy; however, pathogens were tested in
stools at the age of 6 and 9 months using the same TaqMan
array as aforementioned in N = 10 study subjects (parental
refusal for one subject). These have been summarized in
Supplemental Table 6.
Clinical characteristics.Biopsieswere available for further
analysis from a total of 59 children with the following di-
agnoses: normal Western healthy controls (25), EE (10),
Western celiac disease (7),Western non-celiac lymphocytosis
(8), Western non-celiac villous atrophy (7), and Western graft-
versus-host disease (2). Median (Q1 and Q3) ages of subjects
at the time of biopsy ranged from 10 (2–12) months (villous
atrophy subjects) to 30 (12–48) months (GVHD subjects); EE
cases were 22 (20–23) months. The subjects were approxi-
mately equally divided between males (51%, N = 30) and fe-
males (49%, N = 29).
Degrees of villous blunting and intraepithelial lympho-
cytosis differ between EE and other diseases. Villus height
and crypt depth, which indicate damage and regenerative
responses, respectively, are often presented as V:C ratio.
The V:C ratio of EE cases was significantly reduced in EE
cases relative to healthy Western controls (Figures 1 and 2).
This was due to both modest villous blunting and crypt hy-
perplasia. The degree to which V:C ratio was reduced in EE
was comparable to that in western cases of non-celiac vil-
lous atrophy, but far less than the total villous atrophy ob-
served in western celiac disease cases within this age
group. Consistent with loss of villus height and reduced V:C
ratio, villus volumes were also significantly decreased in EE
but were affected more severely in Western celiac disease
(Figure 2).
Increased numbers of intraepithelial T lymphocytes, par-
ticularly within villous epithelium, is a well-characterized fea-
ture of celiac disease and was present in the Western celiac
disease cases analyzed in this study (Figures 1 and 3A and B).
Previous studies have suggested that, as with villous atrophy,
the intraepithelial lymphocytosis in EE is similar to that oc-
curring in celiac disease. However, the cases analyzed here
show that increased intraepithelial lymphocytosis in EE is
more intense than that in all other conditions including celiac
disease (Figures 1 and 3A). Lamina propria T-cell infiltrates in
EEwere also far denser than those in other conditions (Figures
1 and 3B). Thus, although EE histopathology is qualitatively
similar to celiac disease, when analyzed in quantitative terms,
EEdisplays less severe epithelial damageand farmore intense
T-cell infiltrates within both the intraepithelial and lamina
propria compartments.
Mucosa-associated lymphoid tissue induction distin-
guishes EE from celiac disease. Our analyses showed that
lymphoid follicles with germinal centers (Figure 1) were com-
mon in EE biopsies relative to healthy controls and other dis-
eases.Whenquantifying numbersof lymphoid aggregates per
biopsy, our results were notable for more than 60% of EE
biopsies including one of more lymphoid aggregates, with
25% having two or three aggregates per biopsy. We also
quantifiednumbersof lymphoid aggregatesperdiseasegroup
(normal, EE, non-celiac villous atrophy, and non-celiac
lymphocytosis)—of note, 40% of healthy controls and less
than 40% of non-celiac lymphocytosis cases had lymphoid
aggregates. Moreover, few of these hadmore than one follicle
per biopsy fragment. These differences were significant when
EE cases were compared with any of the other groups (P <
0.0001) (Figure 3D). Statistical analysis (two-sided Fisher’s
exact test) confirmed that in the case of H. pylori, pathogen
positivity andpresence of ³2 lymphoid aggregates did not co-
occur more frequently than as expected by chance (P value
not significant). In the case of Giardia, pathogen positivity
and presence of ³ 2 lymphoid aggregates co-occurred more
frequently than as expected by chance (P value < 0.05)
(Supplemental Table 7).
DISCUSSION
The goal of this investigation was to define the duodenal
histopathology of EE in a well-characterized population of
rural Pakistani infants and to compare these findings with
healthy anddisease controls. Our EEcaseswere typical in that
they were typified by maternal illiteracy, infant low birth
weight/preterm status, and multiple micronutrient deficien-
cies. We found that V:C ratios among EE cases were signifi-
cantly different from controls with celiac disease or non-celiac
TABLE 1
Characteristics at the time of biopsy from EE cases and Western
controls
Total population median (Q1–Q3) or n (%)
Diagnosis
Normal 25 (42%)
EE 10 (17%)
Celiac disease 7 (12%)
Lymphocytosis 8 (14%)
Villous atrophy 7 (12%)
Graft vs. host disease 2 (3%)
Age, months*
Normal 12 (12–12)
EE 22 (20–23)
Celiac disease 12 (12–12)
Lymphocytosis 12 (12–12)
Villous atrophy 10 (2–12)
Graft vs. host disease 30 (12–48)
Gender
Female 29 (49%)
Race
African American 9 (15%)
Asian 2 (3%)
South Asian 10 (17%)
Hispanic 2 (3%)
Caucasian 27 (46%)
Unknown 12 (20%)
Total patients N = 59; 61 biopsies obtained from N = 49 Western control patients, 27
biopsies obtained from N = 10 EE biopsy cases. EE = environmental enteropathy.
*Nonparametric comparisons were made between the age of EE subjects and normal,
celiac disease, lymphocytosis, villous atrophy, and graft vs. host disease subjects; age was
significantly different (P < 0.05) in all group comparisons except EE vs. GVHD.
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lymphocytosis. In addition, although both were characterized
by increased numbers of intraepithelial T cells, the magnitude
of these increases in EE was greater than that in celiac dis-
ease. Finally, EE cases had increased lamina propria T-cell
infiltrates and B-cell aggregates, consistent with broader and
more intense lymphocytic recruitment than in celiacdiseaseor
any of the other control categories. This may be related to
altered microbiota, as more than half of the EE cases had
microbial overgrowth as indicated by positive duodenal as-
pirate microbial testing.
FIGURE 1. Duodenal histology and immunohistochemistry in environmental enteropathy (EE). Representative hematoxylin and eosin (H&E) (top)
and immunofluorescence (bottom) images of matched fields for each subject group are shown. Immunofluorescence shows T-cell marker CD3
(red), B-cell marker CD20 (green), and aDNA stain (blue). Boxed areas on lowmagnification images designate the area shown in the inset. Arrows in
the immunofluorescence images designate T cells. The arrowhead in the immunofluorescence image of the EE case indicates a lymphoid ag-
gregate. Scale: low magnification images, bar = 100 μm; insets, bar = 20 μm. The H&E fields shown are of the same regions shown in the
immunofluorescence images. These were selected to best demonstrate the immune infiltrates. In the cases of EE and GVHD, well-oriented
crypt–villus units were not present in the most illustrative immunostained regions.
FIGURE 2. Villus and cryptmorphometry in environmental enteropathy (EE). (A) Villus volumewas calculated by using villus depth and villus width
at 1/3 and 2/3 from the tip of the villus from the biopsies of healthy normal, EE, lymphocytosis, celiac disease, and villous atrophybiopsies. (B) Villus-
to-crypt ratios were measured in healthy normal, EE, lymphocytosis, celiac disease, villous atrophy, and GVHD patient biopsies. Note: one-way
analysis of variance with Bonferroni’s multiple comparison tests was performed with horizontal bars indicating significant results. ****P value <
0.00005; ***P value < 0.0005; **P value < 0.005; *P value < 0.05.
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Prior studies describing the histopathologic features of
the gut mucosa have also been performed in children with a
variety of clinical presentations and sites. For example,
Sullivan et al.29 reported on jejunal biopsies from severely
malnourished Gambian children, all of whom had either
kwashiorkor or marasmus. Conversely, the Gambian chil-
dren studied by Campbell et al.18 were heterogeneous,
with a wide range of nutritional and clinical states (median
weight z score, −4.6; range, 0.5 to −6.4). Finally, studies in
Brazil evaluated asymptomatic children with altered
D-xylose absorption and, on biopsy, moderate villous at-
rophy with lamina propria inflammation. Here, we have
sampled a homogenous group of children, all with
WHZ < −2, who had all failed RUTF nutritional intervention.
As a result, the features we identified in these biopsies are
more likely to be specific for EE rather than across the range
of malnutrition and malabsorptive disorders seen in
impoverished populations.
Previous studies generalized the histopathology of EE as
being identical to celiac disease.29,30 However, even when
compared with our age-matched celiac disease cases,
the EE cases displayed more intense intraepithelial T
lymphocytosis. This is remarkable, given that all of the
celiac disease cases had complete villous atrophy,
whereas villi were relatively preserved in EE.
A previously unrecognized observation is the number of
lamina propriaB lymphocyte aggregates in the EEbiopsieswe
evaluated. Of 27 biopsies from 10 EE patients, all except one
case had at least one B-cell aggregate identified. This was
significantly greater than that seen in celiac disease or other
patient categories evaluated and suggests that B-cell aggre-
gates are common enough to consider a “typical” feature of
EE. It remains to be determinedwhether the presence of B-cell
aggregates, lamina propria T-cell infiltrates, and intraepithelial
T lymphocytosis correlates with the magnitude of the micro-
bial burden or specific microbial changes in EE. Alternatively,
the increased immune cell recruitment could be an adaptive
response to inadequate specific activation of mucosal im-
munity. Consistent with this, we have recently shown that
serum levels of anti-flagellin and anti-lipopolysaccharide IgA
were significantly lower in our cohort of Pakistani infants than
in healthy infants in Boston.31 Similarly, Kau et al.32 have re-
ported a relationship between IgA responses and growth in
two cohorts of Malawian infants and children.
FIGURE 3. Intraepithelial and lamina propria lymphocyte populations in samples from patients with healthy normal, environmental enteropathy
(EE), lymphocytosis, celiac disease, villous atrophy, and GVHD patient biopsies. (A) Intraepithelial CD3+ T lymphocytes. (B) Lamina propria CD3+ T
lymphocytes. (C) Lamina propria CD20+ B lymphocytes. (D) Bar graphs demonstrating percentages of CD20+ B lymphocyte aggregates. For (A–C),
one-way analysis of variance with Bonferroni’smultiple comparison tests was performedwith horizontal bars indicating significant results. For (D),
χ2 comparisons were performed with horizontal bars indicating significant results. ***P value < 0.0005; **P value < 0.005; *P value < 0.05.
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There are several limitations to this study. First, we did not
measure detailed metabolic profiles of our subjects at the time of
endoscopy. Second, the criteria we used to triage and identify
which children needed to get endoscopies included the use of
WHZ scores < −2 and clinical history concerning malabsorption
(historyof recurrent diarrhea, abdominal bloating, etc.),whichwere
broader than those in other prior studies in community settings in
which children were biopsied. As noted in our methods, days and
types of antibiotics received were recorded at monthly visits for
each of the 10 EE biopsy subjects; however, we believe that the
modest numberofpatients, the largevarietyofpathogens, and the
diversity of antimicrobials administered would make a definitive
analysis difficult; thus, these datawere not included in our present
work. The nonindependence of biopsy measures per subject is a
potential limitationandhasbeen includedassuch in the limitations.
As noted before, these are results from a preliminary study, which
we have used to inform a currently ongoing better powered in-
vestigation with larger sample size. An important point to note
would be that the age between our normal controls and EE sub-
jects was significantly different; however, present literature would
suggest that dimensions inhealthynormal intestinal villi andcrypts
change with age such that mean crypt length is longer in infants
with significantly less mean epithelial cell height.33,34 This would
suggest in our groups, the younger “normal” groupwould have
V:C ratios lower than an older “normal” group, suggesting if any-
thingour resultshave likelyunderestimatedthetrueeffectsize.This
has been noted in our discussion also. Finally, maternal data were
relatively limited, the sample size was small, and in-country con-
trols were not available. Nevertheless, our study had important
strengths including the relativehomogeneityofoursubjects,useof
age-matchednormalanddiseasecontrols,anddetailedqualitative
and quantitative analyses of immune cell infiltrates using immu-
nofluorescence microscopy, which provides greater spatial
resolution than enzymatic immunohistochemical methods. Fur-
thermore, although WHZ was our primary criterion for selection
of children for nutritional intervention, children were selected for
biopsy if theyshowedaclinicalconcern formalabsorptionand/or
ponderal and linear growth faltering, as shown in our results.
Because of the overlap in children who were underweight,
wasted, and stunted, we feel our results are relevant to the
height-for-height z score (HAZ) drop that is seen in EE. Indeed,
the 10 EE children biopsied in our study experienced an average
HAZdrop of two z scores frombirth to 22months of age. Finally,
we have demonstrated the safety and ethical and practical fea-
sibility of performing endoscopic evaluation of malnourished
children in the community setting.
In summary, among a birth cohort of rural Pakistani children
at risk of developing EE, we have demonstrated in a subset of
malnourished children that multiple micronutrient deficien-
cies, infections, and characteristic histopathologies coexist.
These findings have important implications both in our un-
derstanding of EE and in developing a clinical case definition
along with identifying future areas that deserve further re-
search. As we come closer to truly understanding the patho-
physiology of gut function amongmalnourished children living
in resource-poor countries, we narrow the gap toward effec-
tive treatments both for improving oral vaccine response and
stunting in these settings.
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